Abstract 1240: RRM2 and mutant p53 as therapeutic targets in TNBC

Authors: Nahid Sultana, Elizabeth A. Wilson, Howard L. Elford, Jesika S. Faridi

Published: 2021-07-01

DOI: 10.1158/1538-7445.am2021-1240

Source: Full article